Cetuximab Harmful for Operable CRC Liver Metastases

<![CDATA[]]>(MedPage Today) — Adding cetuximab (Erbitux) to perioperative chemotherapy worsened survival for colorectal cancer (CRC) patients with operable liver metastases, long-term results from a randomized trial showed.
With over 5 years of follow-up…

Source link

WordPress database error: [Error writing file '/tmp/MYd5PLm8' (Errcode: 28 - No space left on device)]
SELECT SQL_CALC_FOUND_ROWS wp_posts.ID FROM wp_posts LEFT JOIN wp_term_relationships ON (wp_posts.ID = wp_term_relationships.object_id) WHERE 1=1 AND wp_posts.ID NOT IN (337109) AND ( wp_term_relationships.term_taxonomy_id IN (37) ) AND wp_posts.post_type = 'post' AND (wp_posts.post_status = 'publish') GROUP BY wp_posts.ID ORDER BY RAND() LIMIT 0, 3

This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Accept Read More

Privacy & Cookies Policy


COVID-19 (Coronavirus) is a new illness that is having a major effect on all businesses globally LIVE COVID-19 STATISTICS FOR World